PepGen Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	18.04	16.64	14.22	8.11	0.85	0.63
Research & Development	68.5	68.13	54.08	19	1.02	0.73
Operating Expenses	86.53	84.77	68.3	27.11	1.88	1.35
Operating Income	-86.53	-84.77	-68.3	-27.11	-1.88	-1.35
Interest & Investment Income	6.34	6.4	2.79	-	0.01	0.01
Other Non Operating Income (Expenses)	-0.06	-0.19	0.11	-0.17	-0.02	0
Pretax Income	-80.25	-78.55	-65.4	-27.28	-1.89	-1.35
Income Tax Expense	0.07	0.07	3.71	-	-	-
Net Income	-80.33	-78.63	-69.1	-27.28	-1.89	-1.35
Preferred Dividends & Other Adjustments	-	-	-	-	2.19	-
Net Income to Common	-80.33	-78.63	-69.1	-27.28	-4.08	-1.35
Shares Outstanding (Basic)	25	24	16	1	1	1
Shares Outstanding (Diluted)	25	24	16	1	1	1
Shares Change (YoY)	17.25%	52.15%	1635.61%	3.62%	5.40%	-
EPS (Basic)	-3.21	-3.30	-4.42	-30.27	-4.69	-1.63
EPS (Diluted)	-3.21	-3.30	-4.42	-30.27	-4.69	-1.63
Free Cash Flow	-77.58	-71.6	-63.02	-23.1	-1.66	-0.91
Free Cash Flow Per Share	-3.10	-3.01	-4.03	-25.63	-1.91	-1.11
EBITDA	-85.12	-83.58	-67.81	-26.93	-1.77	-1.25
D&A For EBITDA	1.41	1.18	0.49	0.18	0.11	0.11
EBIT	-86.53	-84.77	-68.3	-27.11	-1.88	-1.35

Source: S&P Capital IQ. Standard template.